Aureka Biotechnologies is a premier biotech startup committed to democratizing the pharmaceutical industry to defeat disease. Aureka is developing a best-in-class therapeutic discovery platform that uniquely integrates high-throughput, single-cell-based functional screening, synthetic biology-based autonomous discovery, and generative AI-based therapeutic design and multi-objective optimization. Empowered by large-scale, multi-metric data generated at an unprecedented scale and rapid reinforcement learning, Aureka’s solutions can uncover therapeutic design principles and exponentially accelerate the discovery of a wide range of immunotherapeutic modalities including bispecific antibodies, ADCs, TCR-T, as well as new therapeutics for previously challenging targets and mechanisms such as GPCR.